$40.10 -0.85 (%) Pacira Pharmaceuticals Inc - NASDAQ

Jan. 20, 2017 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Innocol Pain Drug Application Refusal Seen As Positive For Pacira

    TalkMarkets | Dec. 30, 2016 | 11:41AM EST
  2. Pacira A Likely Takeout Candidate Despite Anesthesia Sales Dip: Mizuho

    Investors Business Daily | Dec. 21, 2016 | 13:08PM EST
  3. Benzinga's Top Initiations

    Benzinga | Jan. 5, 2016 | 09:54AM EST
  4. Mariko Gordon Nearly Doubles Stake in Forward Air

    GuruFocus | Jan. 4, 2016 | 17:18PM EST
  5. Pacira Pharmaceuticals Achieves Favorable Resolution With FDA; Reaffirms Broad Indication for EXPAREL

    Benzinga | Dec. 15, 2015 | 04:13AM EST
  6. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 27, 2015 | 08:15AM EST
  7. Pacira Pharmaceuticals Names James S. Scibetta as President

    Benzinga | Oct. 20, 2015 | 06:34AM EST
  8. Animal Health Partner, Aratana Therapeutics, Announces Positive Pivotal Results for Controlling Postsurgical Pain in Dogs

    Benzinga | Jul. 15, 2015 | 07:01AM EST
  9. Aratana Therapeutics Announces Positive Pivotal Results for AT-003

    Benzinga | Jul. 14, 2015 | 15:07PM EST
  10. Benzinga's Top Initiations

    Benzinga | Jun. 19, 2015 | 08:23AM EST
  11. Mallinckrodt: Ofirmev, Acthar And A Nearby Buy Point

    IBD | May. 20, 2015 | 17:31PM EST
  12. Pacira Announces New Data Supporting Clinical and Pharmacoeconomic Utility of EXPAREL in Patients Undergoing Various Surgical Procedures

    Benzinga | May. 19, 2015 | 15:31PM EST
  13. Pacira Pharmaceuticals'

    IBD | Mar. 2, 2015 | 18:45PM EST
  14. Stocks Tack On Gains; Nasdaq Tops 5000 Level

    IBD | Mar. 2, 2015 | 12:01PM EST
  15. Morning Market Losers

    Benzinga | Mar. 2, 2015 | 09:55AM EST
  16. Benzinga's Top #PreMarket Losers

    Benzinga | Mar. 2, 2015 | 08:19AM EST
  17. JPM Securities Picks Through Biotech News For Winners

    Benzinga | Feb. 25, 2015 | 12:41PM EST
  18. Pacira Pharmaceuticals

    IBD | Feb. 24, 2015 | 19:07PM EST
  19. Why These Three Hot Young Stocks Are Worth Watching

    IBD | Feb. 24, 2015 | 17:25PM EST
  20. Stocks Edge Lower, Oil Falls, But Managed-Care Firms Shine

    IBD | Feb. 23, 2015 | 11:47AM EST
  21. 3 Niche ETFs Breaking Out

    Benzinga | Feb. 17, 2015 | 14:42PM EST
  22. More Leading Stocks Showing Better Action

    IBD | Feb. 11, 2015 | 17:50PM EST
  23. Stocks Mixed, Mostly Unchanged; Apple Extends Gains

    IBD | Feb. 11, 2015 | 14:58PM EST
  24. Stocks Mixed In Quiet Session; Pacira, Zoetis Ramp Higher

    IBD | Feb. 11, 2015 | 13:26PM EST
  25. Stocks Stay Mixed; Palo Alto Breaks Out

    IBD | Feb. 11, 2015 | 11:49AM EST
  26. US Stock Futures Edge Lower Ahead Of Earnings

    Benzinga | Feb. 11, 2015 | 07:26AM EST
  27. Wedbush Highlights 2015 Catalysts for Emerging BioPharmaceuticals

    GuruFocus | Feb. 4, 2015 | 13:43PM EST
  28. New Biotech ETF From ALPS

    Benzinga | Jan. 2, 2015 | 08:05AM EST
  29. Pacira Pharma Reports Changes to EXPAREL Label, Indication Not Affected

    Benzinga | Dec. 12, 2014 | 08:33AM EST
  30. SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Pacira ...

    GuruFocus | Nov. 28, 2014 | 11:03AM EST
  31. New Study Correlates Use Of EXPAREL For Postsurgical Pain Management With Significant Reductions In Opioid Related Adverse Events

    Benzinga | Oct. 27, 2014 | 15:13PM EST
  32. Bank Of America Q3 Small & Mid-Cap Biotech Preview

    Benzinga | Oct. 20, 2014 | 15:58PM EST
  33. Pacira Pharma Offers Added Data Support Safety of EXPAREL in Peripheral Nerve Block

    Benzinga | Oct. 13, 2014 | 15:00PM EST
  34. Bank Of America Sees Significant Manufacturing Capacity Expansions Underway For Pacira Pharmaceuticals

    Benzinga | Oct. 8, 2014 | 10:13AM EST
  35. NASDAQ Dips 1.5%; HB Fuller Shares Decline On Downbeat Results

    Benzinga | Sep. 25, 2014 | 11:09AM EST
  36. Markets Tumble; Scholastic Posts Wider Fiscal-First Quarter Loss

    Benzinga | Sep. 25, 2014 | 10:12AM EST
  37. Morning Market Losers

    Benzinga | Sep. 25, 2014 | 08:44AM EST
  38. Benzinga's Top #PreMarket Losers

    Benzinga | Sep. 25, 2014 | 07:11AM EST
  39. US Stock Futures Flat Ahead Of Jobless Claims, Durable-Goods Orders Data

    Benzinga | Sep. 25, 2014 | 06:35AM EST
  40. Pacira Pharmaceuticals, Inc. Announces Receipt of FDA Warning Letter

    Benzinga | Sep. 25, 2014 | 05:59AM EST
  41. Pacira Pharmaceuticals

    IBD | Jul. 31, 2014 | 17:53PM EST
  42. UPDATE: Bank Of America Reiterates On Pacira Pharmaceuticals On Positive Survey Results

    Benzinga | Jul. 17, 2014 | 07:33AM EST
  43. 3 Hot Biotech Stocks Hitting Highs

    Benzinga | Jun. 23, 2014 | 13:00PM EST
  44. UPDATE: JMP Securities Initiates Coverage On Pacira Pharmaceuticals

    Benzinga | Jun. 17, 2014 | 09:43AM EST
  45. Sohn Conference Moves Markets Once Again

    Benzinga | May. 6, 2014 | 15:56PM EST
  46. Benzinga's Volume Movers

    Benzinga | Apr. 9, 2014 | 09:22AM EST
  47. CorMedix Welcomes Additional Board Members

    Benzinga | Apr. 7, 2014 | 07:33AM EST
  48. Mid-Morning Market Update: Markets Open Higher; UTi Worldwide Reports Q4 Loss

    Benzinga | Mar. 31, 2014 | 09:35AM EST
  49. Baron Funds Comments on Pacira Pharmaceuticals

    GuruFocus | Mar. 5, 2014 | 11:26AM EST
  50. UPDATE: Piper Jaffray Downgrades Pacira Pharmaceuticals Following 2Q13 Net Loss

    Benzinga | Aug. 7, 2013 | 07:18AM EST
Trading Center